916596-04-8

Basic information

• Product Name: 3-chloro-4-isopropoxybenzonitrile
• Synonyms: 3-chloro-4-isopropoxybenzonitrile
• CAS NO: 916596-04-8
• Molecular Weight: 195.648
• Mol File: 916596-04-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-chloro-4-isopropoxybenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-4-isopropoxybenzonitrile(916596-04-8)
• EPA Substance Registry System: 3-chloro-4-isopropoxybenzonitrile(916596-04-8)

Safety Data

• Hazardous Substances Data: 916596-04-8(Hazardous Substances Data)

Upstream product

• 2315-81-3 2-chloro-4-cyanophenol 
• 67-63-0 isopropyl alcohol 
• 75-26-3 isopropyl bromide 
• 117482-84-5 3-chloro-4-fluorobenzonitrile 

Downstream Products

• 1035216-81-9 (Z)-3-chloro-N'-hydroxy-4-isopropoxybenzimidamide 
• 1035214-17-5 3-(3-chloro-4-isopropoxyphenyl)-5-(3-chloropyridin-4-yl)-[1,2,4]-oxadiazole 
• 213598-06-2 methyl 3-chloro-4-isopropoxybenzoate 
• 213598-07-3 3-chloro-4-isopropoxy-benzoic acid 
• 1035216-81-9 3-chloro-N'-hydroxy-4-isopropoxy-benzamidine 
• 1035212-67-9 4-[3-(3-chloro-4-isopropoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-3-methyl-pyridine 
• 1035216-68-2 (Z)-3-(4-(3-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)phenyl)acrylic acid 
• 1035216-54-6 (Z)-methyl 3-(4-(3-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)phenyl)acrylate 
• 1035216-52-4 3-(4-(3-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)benzylamino)propane-1,2-diol 

Relevant articles and documents

THIADIAZOLE MODULATORS OF S1P AND METHODS OF MAKING AND USING

The invention is directed to compounds of the formula: wherein each of the variables are defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance treating an autoimmune disease.

A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066

Recently we reported the discovery of a potent and selective CK2α inhibitor CAM4066. This compound inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket). Here we describe in detail the journey that led to the discov

NOVEL OXADIAZOLE COMPOUNDS

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o